What is NDC 83209-190?

83209-190 is the product NDC for Naproxen, Naproxen 500 mg/1 tablet, listed with the FDA by Boswell Pharmacy Services LLC d/b/a BPS Wholesale. It has 7 package NDCs, shown above in 10- and 11-digit form.

Boswell Pharmacy Services LLC d/b/a BPS Wholesale, NDC labeler code 83209. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Naproxen?

189 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Naproxen NDC 83209-190 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)83209-190Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83209-0190Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
83209-190-14	8320901901483209019014	14 TABLET in 1 BLISTER PACK (83209-190-14)Marketed from Aug 23, 2024
83209-190-15	8320901901583209019015	15 TABLET in 1 BLISTER PACK (83209-190-15)Marketed from Aug 23, 2024
83209-190-18	8320901901883209019018	18 TABLET in 1 BLISTER PACK (83209-190-18)Marketed from Aug 23, 2024
83209-190-20	8320901902083209019020	20 TABLET in 1 BLISTER PACK (83209-190-20)Marketed from Aug 23, 2024
83209-190-28	8320901902883209019028	28 TABLET in 1 BLISTER PACK (83209-190-28)Marketed from Aug 23, 2024
83209-190-30	8320901903083209019030	30 TABLET in 1 BLISTER PACK (83209-190-30)Marketed from Aug 23, 2024
83209-190-60	8320901906083209019060	60 TABLET in 1 BLISTER PACK (83209-190-60)Marketed from Aug 23, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Naproxen
Generic name (nonproprietary): naproxen
Active ingredients: Naproxen — 500 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Boswell Pharmacy Services LLC d/b/a BPS WholesaleNDC labeler code 83209
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 078250
Marketing start: Aug 23, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Non-Steroidal (Chemical structure)Cyclooxygenase Inhibitors (Mechanism)
Identifiers: Product ID 83209-190_205aec1c-4e2f-8e0f-e063-6294a90a4ff0SPL ID 205aec1c-4e2f-8e0f-e063-6294a90a4ff0SPL set ID 205b1159-06e5-0d48-e063-6294a90acbd8RxCUI 198014UNII 57Y76R9ATQ
Pharmacologic class: Nonsteroidal Anti-inflammatory Drug

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N483209019014 followed by a unit qualifier and the quantity

Package 83209-0190-14. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 23, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

Naproxen tablets and naproxen sodium tablets are indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis Polyarticular Juvenile Idiopathic Arthritis Naproxen tablets and naproxen sodium tablets are also indicated for: the relief of signs and symptoms of: tendonitis bursitis acute gout the management of: pain primary dysmenorrhea Naproxen tablets and naproxen sodium tablets are non-steroidal anti-inflammatory drugs indicated for: the relief of the signs and symptoms of: rheumatoid arthritis osteoarthritis ankylosing spondylitis polyarticular juvenile idiopathic arthritis Naproxen tablets and naproxen sodium tablets are also indicated …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83209-190

What is NDC 83209-190?: 83209-190 is the product NDC for Naproxen, Naproxen 500 mg/1 tablet, listed with the FDA by Boswell Pharmacy Services LLC d/b/a BPS Wholesale. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Naproxen.
What is the active ingredient?: Naproxen.
Who is the labeler?: Boswell Pharmacy Services LLC d/b/a BPS Wholesale, NDC labeler code 83209. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Naproxen?: 189 other product NDCs are listed under this name. See all Naproxen NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Naproxen NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Naproxen	Naproxen 500 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-092	87441-0092-01
Naproxen	Naproxen 500 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-190	60760-0190-60
Naproxen	Naproxen 500 mg/1	TabletOral	REMEDYREPACK INC.	70518-4750	70518-4750-00
Naproxen	Naproxen 500 mg/1	TabletOral	Coupler LLC	67046-0784	67046-0784-03
Naproxen	Naproxen 250 mg/1	TabletOral	Coupler LLC	67046-0499	67046-0499-03
Naproxen	Naproxen 375 mg/1	TabletOral	Coupler LLC	67046-0500	67046-0500-03
Naproxen	Naproxen 500 mg/1	TabletOral	Coupler LLC	67046-0501	67046-0501-03
Naproxen	Naproxen 375 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-211	11534-0211-01
Naproxen	Naproxen 500 mg/1	Tablet, Delayed releaseOral	Sunrise Pharmaceutical, Inc.	11534-212	11534-0212-01
Naproxen	Naproxen 250 mg/1	TabletOral	REMEDYREPACK INC.	70518-4514	70518-4514-00

All 190 Naproxen NDCs

Other NDCs under ANDA 078250

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 078250
Product	Strength	Form · route	Labeler	Product NDC
Naproxen	Naproxen 500 mg/1	TabletOral	A-S Medication Solutions	50090-0481
Naproxen	Naproxen 500 mg/1	TabletOral	A-S Medication Solutions	50090-0482
Naproxen	Naproxen 500 mg/1	TabletOral	A-S Medication Solutions	50090-0483
Naproxen	Naproxen 375 mg/1	TabletOral	A-S Medication Solutions	50090-1583
Naproxen	Naproxen 375 mg/1	TabletOral	A-S Medication Solutions	50090-1584
Naproxen	Naproxen 375 mg/1	TabletOral	A-S Medication Solutions	50090-1585
Naproxen	Naproxen 250 mg/1	TabletOral	A-S Medication Solutions	50090-2788
Naproxen	Naproxen 500 mg/1	TabletOral	A-S Medication Solutions	50090-7198
Naproxen	Naproxen 500 mg/1	TabletOral	American Health Packaging	60687-491
Naproxen	Naproxen 500 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-190
Naproxen	Naproxen 500 mg/1	TabletOral	Proficient Rx LP	63187-028
Naproxen	Naproxen 250 mg/1	TabletOral	Proficient Rx LP	63187-461
Naproxen	Naproxen 375 mg/1	TabletOral	Proficient Rx LP	63187-535
Naproxen	Naproxen 500 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	66267-153
Naproxen	Naproxen 500 mg/1	TabletOral	NuCare Pharmaceuticals, Inc.	66267-807
Naproxen	Naproxen 250 mg/1	TabletOral	Coupler LLC	67046-0499
Naproxen	Naproxen 375 mg/1	TabletOral	Coupler LLC	67046-0500
Naproxen	Naproxen 500 mg/1	TabletOral	Coupler LLC	67046-0501
Naproxen	Naproxen 250 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-188
Naproxen	Naproxen 375 mg/1	TabletOral	Glenmark Pharmaceuticals Inc., USA	68462-189

Showing 20 of 30.